Eris Lifesciences Limited reports a change in its board or management
In short
Eris Lifesciences Limited informed the Exchange on September 26, 2026, that Mr. has been appointed as a Non-Executive Independent Director of the company with effect from that date. No additional figures or breakdowns were provided. In simple terms, the company added a new independent director to its board, effective September 26, 2026. The appointment is effective from September 26, 2026.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.